Literature DB >> 21398303

Surviving the first hours in sepsis: getting the basics right (an intensivist's perspective).

Ron Daniels1.   

Abstract

Severe sepsis is a major cause of morbidity and mortality, claiming between 36 000 and 64 000 lives annually in the UK, with a mortality rate of 35%. International guidelines for the management of severe sepsis were published in 2004 by the Surviving Sepsis Campaign and condensed into two Care Bundles. In 2010, the Campaign published results from its improvement programme showing that, although an absolute mortality reduction of 5.4% was seen over a 2 year period in line with increasing compliance with the Bundles, reliability was not achieved and Bundle compliance reached only 31%. This article explores current challenges in sepsis care and opportunities for further improvements. Basic care tasks [microbiological sampling and antibiotic delivery within 1 h, fluid resuscitation, and risk stratification using serum lactate (or alternative)] are likely to benefit patients most, yet are unreliably performed. Barriers include lack of awareness and robust process, the lack of supporting controlled trials, and complex diagnostic criteria leading to recognition delays. Reliable, timely delivery of more complex life-saving tasks (such as early goal-directed therapy) demands greater awareness, faster recognition and initiation of basic care, and more effective collaboration between clinicians and nurses on the front line, in critical care and in specialist support services, such as microbiology and infectious diseases. Organizations such as Survive Sepsis, the Surviving Sepsis Campaign and the Global Sepsis Alliance are working to raise awareness and promote further improvement initiatives. Future developments will focus on sepsis biomarkers and microarray techniques to rapidly screen for pathogens, risk stratification using genetic profiling, and the development of novel therapeutic agents targeting immunomodulation.

Entities:  

Mesh:

Year:  2011        PMID: 21398303     DOI: 10.1093/jac/dkq515

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  65 in total

Review 1.  Sepsis: recognition and treatment.

Authors:  J Soong; N Soni
Journal:  Clin Med (Lond)       Date:  2012-06       Impact factor: 2.659

2.  A commentary on the role of molecular technology and automation in clinical diagnostics.

Authors:  Ciara O'Connor; Marie Fitzgibbon; James Powell; Denis Barron; Jim O'Mahony; Lorraine Power; Nuala H O'Connell; Colum Dunne
Journal:  Bioengineered       Date:  2014-03-21       Impact factor: 3.269

3.  Implications of direct amplification for measuring antimicrobial resistance using point-of-care devices.

Authors:  M R Williams; R D Stedtfeld; H Waseem; T Stedtfeld; B Upham; W Khalife; B Etchebarne; M Hughes; J M Tiedje; S A Hashsham
Journal:  Anal Methods       Date:  2017-01-31       Impact factor: 2.896

4.  A lack of synergy between membrane-permeabilizing cationic antimicrobial peptides and conventional antibiotics.

Authors:  Jing He; Charles G Starr; William C Wimley
Journal:  Biochim Biophys Acta       Date:  2014-09-28

5.  Contact-free monitoring of circulation and perfusion dynamics based on the analysis of thermal imagery.

Authors:  Carina Barbosa Pereira; Michael Czaplik; Nikolai Blanik; Rolf Rossaint; Vladimir Blazek; Steffen Leonhardt
Journal:  Biomed Opt Express       Date:  2014-03-05       Impact factor: 3.732

Review 6.  New Consensus Definitions for Sepsis and Septic Shock: Implications for Treatment Strategies and Drug Development?

Authors:  Michael Berry; Brijesh V Patel; Stephen J Brett
Journal:  Drugs       Date:  2017-03       Impact factor: 9.546

Review 7.  A commentary on the disparate perspectives of clinical microbiologists and surgeons: ad hoc antimicrobial use.

Authors:  Nuala H O'Connell; Ciara O'Connor; Jim O'Mahony; Ronstan Lobo; Maria Hayes; Eric Masterson; Michael Larvin; J Calvin Coffey; Colum Dunne
Journal:  Bioengineered       Date:  2014 Jul-Aug       Impact factor: 3.269

8.  Lymph node fibroblastic reticular cell transplants show robust therapeutic efficacy in high-mortality murine sepsis.

Authors:  Anne L Fletcher; Jessica S Elman; Jillian Astarita; Ryan Murray; Nima Saeidi; Joshua D'Rozario; Konstantin Knoblich; Flavian D Brown; Frank A Schildberg; Janice M Nieves; Tracy S P Heng; Richard L Boyd; Shannon J Turley; Biju Parekkadan
Journal:  Sci Transl Med       Date:  2014-08-13       Impact factor: 17.956

9.  WNT ligands contribute to the immune response during septic shock and amplify endotoxemia-driven inflammation in mice.

Authors:  Marcela Gatica-Andrades; Dimitrios Vagenas; Jessica Kling; Tam T K Nguyen; Helen Benham; Ranjeny Thomas; Heinrich Körner; Bala Venkatesh; Jeremy Cohen; Antje Blumenthal
Journal:  Blood Adv       Date:  2017-07-10

10.  A nurse-led protocol improves the time to first dose intravenous antibiotics in septic patients post chemotherapy.

Authors:  Graeme Mattison; Matthew Bilney; Phil Haji-Michael; Tim Cooksley
Journal:  Support Care Cancer       Date:  2016-07-25       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.